Search hospitals > Nebraska > Omaha
Oncology Hematology West PC
Claim this profileOmaha, Nebraska 68130
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
94 reported clinical trials
11 medical researchers
Summary
Oncology Hematology West PC is a medical facility located in Omaha, Nebraska. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Oncology Hematology West PC is involved with conducting 94 clinical trials across 257 conditions. There are 11 research doctors associated with this hospital, such as Ralph Hauke, MD, Brent Tierney, MD, Timothy Huyck, and Robert M. Langdon.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Ralph Hauke, MDNebraska Cancer Specialists2 years of reported clinical research
Expert in Skin Cancer
Expert in Prostate Cancer
36 reported clinical trials
74 drugs studied
Brent Tierney, MDNebraska Methodist Hospital2 years of reported clinical research
Expert in Ovarian Cancer
Expert in Skin Cancer
23 reported clinical trials
42 drugs studied
Timothy HuyckNebraska Methodist Hospital2 years of reported clinical research
Studies Pancreatic Cancer
Studies Stomach Cancer
15 reported clinical trials
31 drugs studied
Robert M. LangdonNebraska Methodist Hospital10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
42 drugs studied
Clinical Trials running at Oncology Hematology West PC
Breast Cancer
Lung Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Bladder Cancer
Ovarian Cancer
Pancreatic Cancer
Kidney Cancer
Stomach Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Oncology Hematology West PC?
Oncology Hematology West PC is a medical facility located in Omaha, Nebraska. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Oncology Hematology West PC is involved with conducting 94 clinical trials across 257 conditions. There are 11 research doctors associated with this hospital, such as Ralph Hauke, MD, Brent Tierney, MD, Timothy Huyck, and Robert M. Langdon.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.